周末重磅！两部门，最新印发！2026年1月1日起正式执行

Core Points - The National Healthcare Security Administration (NHSA) has announced the 2025 version of the National Basic Medical Insurance, Maternity Insurance, and Work Injury Insurance Drug Catalog, along with the first edition of the Commercial Health Insurance Innovative Drug Catalog, which will take effect on January 1, 2026 [1] Group 1: Drug Catalog Updates - The new drug catalog will replace the 2024 version, and local authorities are required to strictly implement the new catalog without making any unauthorized adjustments [1] - A six-month transition period will be provided for drugs that were not successfully renewed in the catalog, allowing for continued payment at original rates until the end of June 2026 [2] Group 2: Management of Medical Insurance Payment Scope - There will be a strengthened management of the medical insurance payment scope, ensuring that only drugs that align with diagnosis, treatment, and the legal indications specified in the drug's instructions are eligible for payment [3] - The NHSA will actively promote the interpretation of the medical insurance payment scope based on feedback from medical institutions [3] Group 3: Promotion of Commercial Health Insurance - The NHSA encourages the inclusion of the innovative drug catalog in the coverage of commercial health insurance, supporting the development of multi-tiered medical security systems [4] - Local healthcare departments are urged to collaborate with relevant agencies to promote the design of new products and update compensation methods based on the innovative drug catalog [4]